| VARIABLE | FREQUENCY (%) |
| Initial clinical presentation |
|
| Asymptomatic | 34 (16.75) |
| Lower urinary tract symptoms | 125 (61.58) |
| Acute urinary retention | 44 (21.67) |
| Complications |
|
| None | 196 (96.55) |
| Paraplegia | 4 (1.97) |
| Hip fractures | 1 (0.49) |
| Lymphoedema | 2 (0.99) |
| DRE findings |
|
| Remarkable | 88 (43.35) |
| Unremarkable | 115 (56.65) |
| BMI ranges |
|
| <18.5 | 1 (0.49) |
| 18.5 - 24.9 | 61 (30.20) |
| 25 - 29.9 | 96 (47.52) |
| 30 - 34.9 | 39 (19.21) |
| 35 - 39.9 | 5 (2.46) |
| ≥40 | 1 (0.49) |
| Serum PSA levels (ng/ml) |
|
| 4 - 40 | 96 (47.29) |
| 40.1 - 80 | 34 (16.75) |
| 80.1 - 120 | 9 (4.43) |
| 120.1 - 160 | 12 (5.91) |
| 160.1 - 200 | 10 (4.93) |
| >200 | 42 (20.69) |
| Anemia |
|
| Yes | 100 (49.26) |
| No | 103 (50.74) |
| Aggressive cancer |
|
| Yes | 36 (17.73) |
| No | 167 (82.27) |
| Prostate volume (ml) |
|
| ≤20 | 5 (2.46) |
| 20.1 - 40 | 41 (20.20) |
| 40.1 - 60 | 61 (30.05) |
| 60.1 - 80 | 46 (22.66) |
| 80.1 - 100 | 23 (11.33) |
| >100 | 27 (13.30) |
| Abnormal echostructure |
|
| Yes | 59 (29.06) |
| No | 144 (70.94) |